颞骨-腮腺切除术治疗腮腺恶性肿瘤:一项系统综述
该系统综述纳入1993至2019年发表的13篇文章共336例患者,评估颞骨-腮腺切除术治疗累及颞骨的腮腺恶性肿瘤的生存结局与切缘状态。74.5%的病例实现了阴性手术切缘,中位随访32个月后64.0%的患者获得局部疾病控制,51.4%的患者在随访期间出现远处转移。
要点
- 336例患者中74.5%实现阴性手术切缘,中位随访32个月后64.0%获得局部疾病控制。
- 51.4%的患者在随访期间出现远处转移。
- 3年总生存率和疾病特异性生存率分别在72.4%-57.1%和79.0%-66.7%之间。
核心结论
- 颞骨-腮腺切除术是实现安全肿瘤学切缘和 adequate 局部疾病控制的可行策略,适用于腮腺恶性肿瘤浸润或毗邻颞骨的患者。
- 研究结果支持对颞骨-腮腺切除术日益增长的兴趣,并强调需要进一步研究以完善患者选择标准、手术技术和术后管理策略。
研究设计与样本
- 系统综述,方案于2024年2月在PROSPERO注册(CRD42024512013),按照PRISMA方法进行。
- 检索PubMed、Scopus和Embase数据库至2025年2月11日,纳入1993至2019年发表的13篇文章,共336例患者。
主要发现
- 74.5%的病例实现了阴性手术切缘。
- 中位随访32个月后,64.0%的患者获得局部疾病控制。
- 51.4%的患者在随访期间出现远处转移。
- 3年总生存率在72.4%-57.1%之间,3年疾病特异性生存率在79.0%-66.7%之间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgery involving the skull base has recently gained significant prominence in treatment of head and neck cancer. "En bloc temporal-parotid resection," as applied in primary malignancies of the external ear, should be considered as a shift in the surgical landscape of "extended total parotidectomies" to achieve negative surgical margins and decrease the risk of tumor spillage during the procedure. The purpose of this systematic review is to evaluate survival outcomes and margin status in patients with parotid malignancies involving the temporal bone and treated with temporal-parotid resection (TPR). DATA SOURCES: PubMed, Scopus, and Embase databases were systematically searched until 11 February 2025. REVIEW METHODS: The protocol of this investigation was registered on PROSPERO in February 2024 and the systematic review was performed according to the PRISMA method. RESULTS: The study included 336 patients from 13 articles published between 1993 and 2019. Negative surgical margins were achieved in 74.5% of cases. After a median follow-up of 32 months, 64.0% of patients achieved local disease control. Most patients (51.4%) experienced distant metastases during follow-up. Three-year overall survival (OS) and disease-specific survival (DSS) ranged between 72.4%-57.1% and 79.0%-66.7%, respectively. CONCLUSION: TPR represents a viable strategy to achieve safe oncological margins and adequate local disease control in patients with parotid gland malignancies infiltrating or abutting the temporal bone. Our findings support the growing interest in TPR, highlighting the need for further studies to refine patient selection criteria, surgical techniques, and postoperative management strategies. TRIAL REGISTRATION: PROSPERO: CRD42024512013 LEVEL OF EVIDENCE: NA.
引用
- Daloiso A, Cazzador D, Tealdo G, et al. Temporal-Parotid Resection for Malignant Parotid Tumors: A Systematic Review. Laryngoscope. 2025. PMID: 40365836. doi:10.1002/lary.32267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。